Cargando…
Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics
This study aimed to investigate the value of magnetic resonance (MR) characteristics in differentiating the subtypes of growth hormone pituitary adenomas. MATERIALS AND METHODS: The clinical and MR imaging data of 70 patients with growth hormone pituitary adenoma confirmed by surgery and pathology w...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763249/ https://www.ncbi.nlm.nih.gov/pubmed/35099144 http://dx.doi.org/10.1097/RCT.0000000000001249 |
_version_ | 1784633897669099520 |
---|---|
author | Liu, Chen-Xi Wang, Sheng-Zhong Heng, Li-Jun Han, Yu Ma, Yu-Hui Yan, Lin-Feng Yu, Ying Wang, Wen Hu, Yu-Chuan Cui, Guang-Bin |
author_facet | Liu, Chen-Xi Wang, Sheng-Zhong Heng, Li-Jun Han, Yu Ma, Yu-Hui Yan, Lin-Feng Yu, Ying Wang, Wen Hu, Yu-Chuan Cui, Guang-Bin |
author_sort | Liu, Chen-Xi |
collection | PubMed |
description | This study aimed to investigate the value of magnetic resonance (MR) characteristics in differentiating the subtypes of growth hormone pituitary adenomas. MATERIALS AND METHODS: The clinical and MR imaging data of 70 patients with growth hormone pituitary adenoma confirmed by surgery and pathology were retrospectively analyzed. The tumors were divided into dense granular (DG; 36 cases) and sparse granular subtypes (SG; 34 cases). The tumors' MR features were analyzed, including the mean and maximum diameters, T2 signal intensity, T2 relative signal intensity (rSI), homogeneity, enhancement degree, and invasiveness (Knosp grade). Mann-Whitney U test and χ(2) test were used to analyze MR characteristics between the 2 groups. The independent predictors and predictive probabilities of tumor subtypes were obtained via a logistic regression model, and the efficacy was compared by receiver operating characteristic curve. RESULTS: The mean and maximum diameters of growth hormone adenoma in DG and SG were 1.77 versus 2.45 and 1.95 versus 3.00 cm (median, P < 0.05), respectively. There was a significant difference between the 2 groups in T2 signal intensity and rSI (P values were 0.02 and 0.001, respectively). Most DG adenomas (86.1%) appeared as hypointense on T2 images, and 38.2% of SG adenomas were hyperintense. There was no significant difference in tumor homogeneity (P = 0.622). A significant difference was found in the Knosp grade between the 2 subtypes (P = 0.004). In addition, the enhancement degree of SG adenomas was significantly higher than that of DG adenomas (P = 0.001). Logistic regression analysis showed that high T2 rSI value and marked contrast enhancement were independent predictors of the 2 subtypes, and the odds ratios were 4.811 and 4.649, respectively. The multivariate logistic model obtained relatively high predicting efficacy, and the area under the curve, sensitivity, and specificity were 0.765, 0.882, and 0.500, respectively. CONCLUSIONS: There are significant differences in tumor size, T2 signal intensity, T2 rSI, enhancement degree, and invasiveness between DG and SG adenomas. The logistic model based on the marked contrast enhancement and high T2 rSI value has an important value in predicting the subtype of growth hormone adenoma. |
format | Online Article Text |
id | pubmed-8763249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-87632492022-01-21 Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics Liu, Chen-Xi Wang, Sheng-Zhong Heng, Li-Jun Han, Yu Ma, Yu-Hui Yan, Lin-Feng Yu, Ying Wang, Wen Hu, Yu-Chuan Cui, Guang-Bin J Comput Assist Tomogr Neuroimaging: Brain This study aimed to investigate the value of magnetic resonance (MR) characteristics in differentiating the subtypes of growth hormone pituitary adenomas. MATERIALS AND METHODS: The clinical and MR imaging data of 70 patients with growth hormone pituitary adenoma confirmed by surgery and pathology were retrospectively analyzed. The tumors were divided into dense granular (DG; 36 cases) and sparse granular subtypes (SG; 34 cases). The tumors' MR features were analyzed, including the mean and maximum diameters, T2 signal intensity, T2 relative signal intensity (rSI), homogeneity, enhancement degree, and invasiveness (Knosp grade). Mann-Whitney U test and χ(2) test were used to analyze MR characteristics between the 2 groups. The independent predictors and predictive probabilities of tumor subtypes were obtained via a logistic regression model, and the efficacy was compared by receiver operating characteristic curve. RESULTS: The mean and maximum diameters of growth hormone adenoma in DG and SG were 1.77 versus 2.45 and 1.95 versus 3.00 cm (median, P < 0.05), respectively. There was a significant difference between the 2 groups in T2 signal intensity and rSI (P values were 0.02 and 0.001, respectively). Most DG adenomas (86.1%) appeared as hypointense on T2 images, and 38.2% of SG adenomas were hyperintense. There was no significant difference in tumor homogeneity (P = 0.622). A significant difference was found in the Knosp grade between the 2 subtypes (P = 0.004). In addition, the enhancement degree of SG adenomas was significantly higher than that of DG adenomas (P = 0.001). Logistic regression analysis showed that high T2 rSI value and marked contrast enhancement were independent predictors of the 2 subtypes, and the odds ratios were 4.811 and 4.649, respectively. The multivariate logistic model obtained relatively high predicting efficacy, and the area under the curve, sensitivity, and specificity were 0.765, 0.882, and 0.500, respectively. CONCLUSIONS: There are significant differences in tumor size, T2 signal intensity, T2 rSI, enhancement degree, and invasiveness between DG and SG adenomas. The logistic model based on the marked contrast enhancement and high T2 rSI value has an important value in predicting the subtype of growth hormone adenoma. Lippincott Williams & Wilkins 2022 2021-11-11 /pmc/articles/PMC8763249/ /pubmed/35099144 http://dx.doi.org/10.1097/RCT.0000000000001249 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Neuroimaging: Brain Liu, Chen-Xi Wang, Sheng-Zhong Heng, Li-Jun Han, Yu Ma, Yu-Hui Yan, Lin-Feng Yu, Ying Wang, Wen Hu, Yu-Chuan Cui, Guang-Bin Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics |
title | Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics |
title_full | Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics |
title_fullStr | Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics |
title_full_unstemmed | Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics |
title_short | Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics |
title_sort | predicting subtype of growth hormone pituitary adenoma based on magnetic resonance imaging characteristics |
topic | Neuroimaging: Brain |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763249/ https://www.ncbi.nlm.nih.gov/pubmed/35099144 http://dx.doi.org/10.1097/RCT.0000000000001249 |
work_keys_str_mv | AT liuchenxi predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT wangshengzhong predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT henglijun predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT hanyu predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT mayuhui predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT yanlinfeng predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT yuying predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT wangwen predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT huyuchuan predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics AT cuiguangbin predictingsubtypeofgrowthhormonepituitaryadenomabasedonmagneticresonanceimagingcharacteristics |